StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
In his latest research note, analyst Trung Huynh confirms his recommendation. The broker UBS is keeping its Neutral rating. The target price remains unchanged at USD 28.